NOXXON Announces Enrollment of First Patient in the Expansion of the NOX-A12 Phase I/II Trial in Brain Cancer

NOXXON Pharma N.V. announced that the first patient was enrolled in an expansion arm of the GLORIA clinical trial of NOX-A12 in MGMT unmethylated brain cancer.